TREA

85082509 - IMMIPRINT

Follow

Information

  • Trademark
  • 85082509
  • Serial Number
    85082509
  • Filing Date
    July 12, 2010
    14 years ago
  • Transaction Date
    November 14, 2013
    11 years ago
  • Status Date
    November 14, 2013
    11 years ago
  • Published for Opposition Date
    September 20, 2011
    13 years ago
  • Location Date
    May 18, 2012
    12 years ago
  • Status Code
    605
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    WATSON, JULIE A
  • Attorney Docket Number
    15128
    Attorney Name
    Howard N. Aronson
    Law Office Assigned Location Code
    L90
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
IMMIPRINT
Case File Statements
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0011: Chemical and biochemical assays and reagents for use in science, industrial research and medical research
  • GS0051: Medical and veterinary diagnostic test set-ups composed primarily of chemical and/or biochemical reagents used in diagnosing human and animal diseases; diagnostic preparations for medical and veterinary purposes; chemical reagents for medical or veterinary purposes; reagents for medical or veterinary diagnostic purposes
  • GS0101: Apparatus for clinical, medical and veterinary diagnosis, namely, microplate readers for blood and body fluid based diagnostic testing, antibody bio-chips for blood and body fluid based diagnostic testing, flow cytometers for blood and body fluid based diagnostic testing, immuno detectors for blood and body fluid based diagnostic testing, microfluidic biochips for blood and body fluid based diagnostic testing, photometers for blood and body fluid based diagnostic testing, piezo electrical transducers for blood and body fluid based diagnostic testing, acoustic detectors and mass spectrometers for blood and body fluid based diagnostic testing: medical and veterinary testing apparatus for diagnosing human and animal diseases, in particular ones containing chemical and/or biochemical reagents, namely, microplate readers for blood and body fluid based diagnostic testing, antibody bio-chips for blood and body fluid based diagnostic testing, flow cytometers for blood and body fluid based diagnostic testing, immuno detectors for blood and body fluid based diagnostic testing, microfluidic bio-chips for blood and body fluid based diagnostic testing, photometers for blood and body fluid based diagnostic testing, piezo electrical transducers for blood and body fluid based diagnostic testing, acoustic detectors and mass spectrometers for blood and body fluid based diagnostic testing; laboratory apparatus and equipment for use in the detection of soluble CD antigens, soluble immune system proteins and other soluble proteins in bodily fluids all for diagnosis and monitoring of human and animal diseases and for the monitoring of treatments and therapies for human and animal diseases, namely, microplate readers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, antibody biochips for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, flow cytometers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, immuno detectors for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, microfluidic bio-chips for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, photometers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, piezo electrical transducers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, acoustic detectors and mass spectrometers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification; scientific apparatus and equipment for use in the detection of soluble CD antigens, soluble immune system proteins and other soluble proteins in bodily fluids all for use in the diagnosis and monitoring of human and animal diseases and for the monitoring of treatments and therapies for human and animal diseases, namely, microplate readers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, antibody bio-chips for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, flow cytometers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, immuno detectors for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, microfluidic bio-chips for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, photometers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, piezo electrical transducers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, acoustic detectors and mass spectrometers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification
  • GS0441: Medical analyses, namely, RNA or DNA analyses for diagnosing human and animal diseases and forecasting the expected progress of human and animal diseases, all provided during the course of medical treatment or diagnosis and not for medical research purposes
Case File Event Statements
  • 11/14/2013 - 11 years ago
    38 - ABANDONMENT NOTICE MAILED - AFTER PUBLICATION Type: MAB5
  • 11/14/2013 - 11 years ago
    37 - ABANDONMENT - AFTER PUBLICATION Type: ABN5
  • 11/13/2013 - 11 years ago
    36 - TEAS EXPRESS ABANDONMENT RECEIVED Type: EXAR
  • 5/16/2013 - 11 years ago
    35 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 5/15/2013 - 11 years ago
    34 - EXTENSION 3 GRANTED Type: EX3G
  • 5/10/2013 - 11 years ago
    33 - EXTENSION 3 FILED Type: EXT3
  • 5/10/2013 - 11 years ago
    32 - TEAS EXTENSION RECEIVED Type: EEXT
  • 11/14/2012 - 12 years ago
    31 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 11/13/2012 - 12 years ago
    30 - EXTENSION 2 GRANTED Type: EX2G
  • 11/9/2012 - 12 years ago
    29 - EXTENSION 2 FILED Type: EXT2
  • 11/9/2012 - 12 years ago
    28 - TEAS EXTENSION RECEIVED Type: EEXT
  • 5/22/2012 - 12 years ago
    27 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 5/18/2012 - 12 years ago
    26 - EXTENSION 1 GRANTED Type: EX1G
  • 4/26/2012 - 12 years ago
    25 - EXTENSION 1 FILED Type: EXT1
  • 5/18/2012 - 12 years ago
    24 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 4/26/2012 - 12 years ago
    23 - TEAS EXTENSION RECEIVED Type: EEXT
  • 11/15/2011 - 13 years ago
    22 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 9/20/2011 - 13 years ago
    21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/20/2011 - 13 years ago
    20 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/17/2011 - 13 years ago
    19 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 8/8/2011 - 13 years ago
    18 - ASSIGNED TO LIE Type: ALIE
  • 7/26/2011 - 13 years ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/26/2011 - 13 years ago
    16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 7/26/2011 - 13 years ago
    15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 7/26/2011 - 13 years ago
    14 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 7/26/2011 - 13 years ago
    13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 2/7/2011 - 14 years ago
    12 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 2/7/2011 - 14 years ago
    11 - FINAL REFUSAL E-MAILED Type: GNFR
  • 2/7/2011 - 14 years ago
    10 - FINAL REFUSAL WRITTEN Type: CNFR
  • 1/18/2011 - 14 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/17/2011 - 14 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/17/2011 - 14 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/25/2010 - 14 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 10/25/2010 - 14 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 10/25/2010 - 14 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 10/25/2010 - 14 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/15/2010 - 14 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 7/15/2010 - 14 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP